The study reveals the structural basis for chloramphenicol binding to the E. coli adhesin DraE, showing a novel binding mechanism mediated by the chlorine tail.
No takes yet. Share an insight, caveat, or question.
Does not support clinical changes in chloramphenicol use; leaves open whether chlorine-tail recognition enables DraE-targeted therapies.
Pettigrew et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: